Stay updated with breaking news from Mark Swallow Phd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Dunad Therapeutics ("Dunad"), a biopharmaceutical company focusing on the development of next-generation targeted protein degradation...
BOSTON and LONDON, May 5, 2021 /PRNewswire/ -- The Dementia Discovery Fund (DDF), the venture capital fund investing in, and creating, biotech companies pursuing transformational therapeutic
Enterome strengthens its leadership team with the appointment of Anne Dagallier as Chief Business Officer PARIS, March 10, 2021 /PRNewswire/ -- ENTEROME SA, a clinical stage biopharmaceutical company developing novel therapeutics based on its unique ability to de-code molecular interactions in the gut microbiome impacting human health, is pleased to announce the appointment of Anne Dagallier, PhD, as Chief Business Officer (CBO). Dr Dagallier brings over 22 years of experience in global business and drug development. She joins Enterome after 19 years at Sanofi where she held several scienti...
New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million Ventyx Biosciences combines clinical stage programs of three companies co-founded and merged by New Science Ventures News provided by Share this article Share this article NEW YORK and LONDON, March 9, 2021 /PRNewswire/ -- New Science Ventures LLC ("NSV"), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, announces that its portfolio company Ventyx Biosciences raised $114 million from blue-chip investors to advance a diverse pipeline of im...
New Science Ventures announces merger of its portfolio company Achronix with ACE Convergence News provided by Share this article Share this article NEW YORK and LONDON, Jan. 12, 2021 /PRNewswire/ -- New Science Ventures LLC ("NSV"), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, today announces the merger of its portfolio company, Achronix Semiconductor Corporation ("Achronix"), with ACE Convergence Acquisition Corp. NSV is a founding investor in Achronix. Highlights : Achronix is the only independent supplier o...